Guidelines for NHL: Updates to the Management of DLBCL and New Guidelines for T-Cell Lymphoproliferative Disorders
This information was originally presented on March 13, 2014, at the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.
This activity is designed to meet the educational needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Integrate into professional practice the key updates of the NCCN Guidelines related to non-Hodgkin’s lymphomas
- Summarize the recent updates to the recommendations for treatment and surveillance of patients with DLBCL
- Discuss the diagnostic and management recommendations for T-cell lymphoproliferative disorders
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center
- 1.00 Participation
- 0.96 Nurse
- 1.00 Pharmacist
- 1.00 Physician